Search

everythinglearnresearchcommunity

for

Search:↓

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

People with alopecia areata often have lower iron levels than healthy people.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Non-immune factors play a significant role in alopecia areata.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.